Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05403983
Other study ID # 101075
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 15, 2022
Est. completion date May 31, 2023

Study information

Verified date December 2023
Source University of the Fraser Valley
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a mixed-methods randomized controlled trial assessing the effects of an online and in person 12-week movement intervention compared to an education only control group on heart rate variability, self-compassion, psychological well-being, fatigue, exercise self-efficacy, physical activity identity, and body image in postpartum women.


Description:

This is a mixed-methods randomized controlled trial assessing the effects of an online and in person 12-week movement intervention compared to an education only control group on heart rate variability, self-compassion, psychological well-being, fatigue, exercise self-efficacy, physical activity identity, and body image in postpartum women. Participants will be randomized into one of three groups: 1) in person yoga movement intervention, 2) online yoga movement intervention, 3) education group. Heart rate variability will be measured using a chest strap at the beginning and end of the 12 week intervention. At the beginning and end of the 12 week intervention, and at 3-months post-intervention, questionnaires will be completed online to assess self-compassion, psychological well-being, fatigue, exercise self-efficacy, physical activity identity, and body image.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date May 31, 2023
Est. primary completion date May 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years and older
Eligibility Inclusion Criteria: - Women who have given birth to a child within the past 6 months and who are cleared for physical activity by their health care provider. Exclusion Criteria: - Participants who have a medical condition that precludes them passing the Get Active questionnaire - Women not clear for physical activity by a health care provider - Participants who are not able to attend classes at pre-specified times

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Yoga movement intervention
Mixture of yoga, tai chi, pilates. Will be delivered in person (experimental) and online (active comparator)
Other:
Education booklet
Recently published postpartum physical activity guidebook through the Sport Information Resource Center of Canada

Locations

Country Name City State
Canada University of the Fraser Valley Chilliwack British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of the Fraser Valley Les Mills International

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Heart rate variability Waking RMSDD heart rate variability (chest strap) Baseline, 12 weeks
Primary Self compassion Self-compassion scale, maximum score 125. Minimum score 25. Higher score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Physical activity Type, amount and frequency of planned exercise, and walking bouts Baseline, 12 weeks, 3 months
Secondary Self efficacy Self-efficacy and barrier to exercise scale. Maximum score of 36. Minimum score of 9. Lower score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Fear of self-compassion Fear of self-compassion scale. Maximum score of 60. Minimum score of 0. Lower score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Fatigue Multidimensional fatigue inventory scale. Maximum score is 100. Minimum score is 20. Lower score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Sleep quality Patient Reported Outcomes Measurement Information System (PROMIS) sleep questionnaire. Maximum score of 40. Minimum score of 8. Lower score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Perceived stress Perceived stress scale. Maximum score of 40. Minimum score of 0. Lower score is a better outcome. Baseline, 12 weeks, 3 months
Secondary Physical activity identify Athlete identity measurement scale. Maximum score of 49. Minimum score is 7. Higher score is better outcome. Baseline, 12 weeks, 3 months
Secondary Body image Body dissatisfaction scale. Maximum score of 48. Minimum score of 8. Lower score is better outcome. Baseline, 12 weeks, 3 months
Secondary Motivation for exercise Psychological needs for exercise scale. Maximum score of 55. Minimum score of 11. Higher score is better outcome. Baseline, 12 weeks, 3 months
Secondary Postpartum depression Edinburgh postnatal depression scale. Maximum score is 30. Minimum score is 0. Lower score is better outcome. Baseline, 12 weeks, 3 months
Secondary Anxiety State-trait anxiety scale. Maximum score of 80. Minimum score of 20. Higher score is better outcome. Baseline, 12 weeks, 3 months
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3